Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
3
×
national blog main
san francisco blog main
astellas pharma
boston blog main
boston top stories
cancer
clinical trials
national top stories
new york blog main
san diego blog main
san francisco
san francisco top stories
10x genomics
atlas venture
audentes therapeutics
avidity biosciences
becton dickinson
bluebird bio
boston
cancer diagnostics
cancer drugs
colorectal cancer
deals
diagnostic device
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
idiopathic pulmonary fibrosis (ipf)
ipo
joshua brumm
kaleido biosciences
lung cancer
lymphoma
mark goldsmith
medical device
merck
muscular dystrophy
What
reach
3
×
ipo
medicines
adding
ago
aims
biotechs
cancer
cancer’s
company
considering
data
deal
decisions
diagnostic
diagnostics
disease
diseases
drug
dyne
early
expand
expected
experimental
eyes
fold
frontiers
genetic
having
help
humans
ipos
known
long
make
maps
muscle
nanostring
parlance
pharmaceutical
Language
unset
3
×
Current search:
reach
×
unset
×
" life sciences "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal